These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A double-blind study of zimelidine, a serotonin uptake inhibitor, and desipramine, a norepinephrine uptake inhibitor, in endogenous depression: clinical and biochemical findings. Aberg-Wistedt A, Ross SB, Jostell KG, Sjöquist B. Adv Biochem Psychopharmacol; 1984; 39():439-47. PubMed ID: 6205564 [No Abstract] [Full Text] [Related]
3. Controlled cross-over study of a 5-HT uptake inhibiting and an NA uptake inhibiting antidepressant. Aberg A. Acta Psychiatr Scand Suppl; 1981; 290():244-55. PubMed ID: 6452794 [Abstract] [Full Text] [Related]
4. Effects of zimelidine and desipramine on serotonin and noradrenaline uptake mechanisms in relation to plasma concentrations and to therapeutic effects during treatment of depression. Aberg-Wistedt A, Jostell KG, Ross SB, Westerlund D. Psychopharmacology (Berl); 1981; 74(4):297-305. PubMed ID: 6457309 [Abstract] [Full Text] [Related]
8. [Development of subsensitivity to imipramine in the system of reverse serotonin uptake by thrombocytes in patients with endogenous depression]. Brusov OS, Beliaev BS, Katasonov AB, Zlobina GP, Faktor MI. Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(9):96-100. PubMed ID: 3232463 [Abstract] [Full Text] [Related]
9. Uptake of 5-hydroxytryptamine by blood platelets incubated in plasma from rats and humans treated with amitriptyline and imipramine. Tukiainen E. Med Biol; 1981 Apr; 59(2):121-6. PubMed ID: 7311628 [Abstract] [Full Text] [Related]
10. Excessive plasma concentration of tricyclic antidepressants resulting from usual doses: a report of six cases. Devane CL, Wolin RE, Rovere RA, Panahon NC, Sutfin TA, Jusko WJ. J Clin Psychiatry; 1981 Apr; 42(4):143-7. PubMed ID: 7204359 [Abstract] [Full Text] [Related]
11. Lithium addition in antidepressant-resistant depression: effects on platelet 5-HT, plasma 5-HT and plasma 5-HIAA concentration. Birkenhäger TK, van den Broek WW, Fekkes D, Mulder PG, Moleman P, Bruijn JA. Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun 30; 31(5):1084-8. PubMed ID: 17467132 [Abstract] [Full Text] [Related]
12. Uptake of 5-hydroxytryptamine and dopamine into platelets from depressed patients and normal subjects--influence of clomipramine, desmethylclomipramine and maprotiline. Ehsanullah RS. Postgrad Med J; 1980 Jun 30; 56 Suppl 1():31-5. PubMed ID: 7393826 [Abstract] [Full Text] [Related]
15. Kinetic effects of desmethylimipramine treatment on platelet serotonin uptake in depressed patients: a comparison with imipramine. Rausch JL, Moeller FG. Psychiatry Res; 1991 Mar 30; 36(3):299-305. PubMed ID: 2062971 [Abstract] [Full Text] [Related]
16. Fluvoxamine-induced alterations in plasma concentrations of imipramine and desipramine in depressed patients. Spina E, Pollicino AM, Avenoso A, Campo GM, Caputi AP. Int J Clin Pharmacol Res; 1993 Mar 30; 13(3):167-71. PubMed ID: 8225700 [Abstract] [Full Text] [Related]
19. The action of antidepressant drugs on 5-hydroxy-tryptamine uptake by platelets--relationship to therapeutic effect. Coppen A, Swade C, Wood K. Acta Psychiatr Scand Suppl; 1981 Mar 30; 290():236-43. PubMed ID: 6939313 [Abstract] [Full Text] [Related]
20. A common uptake system for serotonin and dopamine in human platelets. Omenn GS, Smith LT. J Clin Invest; 1978 Aug 30; 62(2):235-40. PubMed ID: 670392 [Abstract] [Full Text] [Related] Page: [Next] [New Search]